{
    "organizations": [],
    "uuid": "613901a5b952014498501382c8458e5c7386ef48",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cumberland-pharma-says-data-demons/brief-cumberland-pharma-says-data-demonstrates-amifostine-reduces-gastro-intestinal-toxicity-for-multiple-myeloma-patients-idUSFWN1PP18P",
    "ord_in_thread": 0,
    "title": "BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 30, 2018 / 3:49 PM / in 13 minutes BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients Reuters Staff 1 Min Read \nJan 30 (Reuters) - Cumberland Pharmaceuticals Inc: \n* CUMBERLAND PHARMACEUTICALS INC - NEWLY PUBLISHED DATA DEMONSTRATES AMIFOSTINE REDUCES GASTRO-INTESTINAL TOXICITY FOR MULTIPLE MYELOMA PATIENTS Source text for Eikon: Further company coverage:",
    "published": "2018-01-30T17:49:00.000+02:00",
    "crawled": "2018-01-30T18:17:19.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharma",
        "say",
        "data",
        "demonstrates",
        "amifostine",
        "reduces",
        "toxicity",
        "multiple",
        "myeloma",
        "patient",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "cumberland",
        "pharmaceutical",
        "inc",
        "cumberland",
        "pharmaceutical",
        "inc",
        "newly",
        "published",
        "data",
        "demonstrates",
        "amifostine",
        "reduces",
        "toxicity",
        "multiple",
        "myeloma",
        "patient",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}